Quest Diagnostics earns FDA breakthrough designation for adeno-associated virus test

Quest Diagnostics has been granted a breakthrough device designation from the FDA for its adeno-associated virus test.

Related Keywords

,Quest Diagnostics ,Sarepta Therapeutic ,Fda ,Adeno Associated Virus ,Pest ,Sarepta Therapeutics ,Elevidys ,Gene Therapy ,Duchenne Muscular Dystrophy ,Collaboration ,Clinical Lab Testing ,